These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. PET and PET/CT in pediatric oncology. Jadvar H; Connolly LP; Fahey FH; Shulkin BL Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239 [TBL] [Abstract][Full Text] [Related]
6. PET and drug research and development. Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137 [TBL] [Abstract][Full Text] [Related]
7. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Zanzonico P; Dauer L; St Germain J Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography in drug development. Rubin RH; Fischman AJ Q J Nucl Med; 1997 Jun; 41(2):171-5. PubMed ID: 9203856 [TBL] [Abstract][Full Text] [Related]
9. [Symposium: New methods of research in clinical pharmacology. Paris, 19-20 March 1987. Abstracts]. Therapie; 1987; Suppl():81-165. PubMed ID: 3495046 [No Abstract] [Full Text] [Related]
10. Effects of radioactive decay and their implications on in vivo metabolic imaging. Kouris K; Jackson DF Am J Physiol Imaging; 1987; 2(1):44-7. PubMed ID: 3502528 [TBL] [Abstract][Full Text] [Related]
11. Dedicated small animal scanners: a new tool for drug development? Hume SP; Myers R Curr Pharm Des; 2002; 8(16):1497-511. PubMed ID: 12052208 [TBL] [Abstract][Full Text] [Related]
13. PET in drug discovery and development: an introduction. Scheinin H; Scheinin M; Knuuti J Ann Med; 1999 Dec; 31(6):430-1. PubMed ID: 10680857 [No Abstract] [Full Text] [Related]
14. Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response. Aellig WH Br J Clin Pharmacol; 1990 Feb; 29(2):157-67. PubMed ID: 2407281 [No Abstract] [Full Text] [Related]
15. [Thoughts on clinical pharmacology]. Modr Z Cas Lek Cesk; 1988 Jun; 127(23):710-4. PubMed ID: 3401903 [No Abstract] [Full Text] [Related]
16. Constant temperature apparatus for increasing the solubility of drugs for injection. EASTERDAY OD Arch Int Pharmacodyn Ther; 1957 Oct; 112(1-2):50-6. PubMed ID: 13498837 [No Abstract] [Full Text] [Related]
17. The use of imaging as biomarkers in drug development: regulatory issues worldwide. Katz R; Wagner HN; Fauntleroy M; Kuwert T; Frank R J Clin Pharmacol; 2001 Jul; 41(S7):118S. PubMed ID: 11452719 [No Abstract] [Full Text] [Related]
18. A simple device for recording the action of drugs on motility of rats. SCHUTZ F J Physiol; 1946 Jul; 105():20. PubMed ID: 20994092 [No Abstract] [Full Text] [Related]
19. Positron emission tomography: from production and distribution to drug research and clinical applications. Coleman RE; Bednarczyk EM; Chilton H J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S66-7. PubMed ID: 11029876 [TBL] [Abstract][Full Text] [Related]